More than 50% of the patients in our study received second-line chemotherapy, which was associated with a highly significant survival benefit (HR for mortality, 0.639; 95% CI, 0.597–0.684).
← all excerpts
The Trends and Outcomes of Initial Palliative Chemotherapy in Patients with Pancreatic Cancer in Korea Based on National Health Insurance Service Data.
2
—
—
The sentences
Conclusions Our study analyzed a large cohort of patients with PC undergoing initial palliative chemotherapy and revealed an increasing trend in the number of patients over time.